Data as of Dec 19
| +0.22 / +3.94%|
The 6 analysts offering 12-month price forecasts for Evoke Pharma Inc have a median target of 18.50, with a high estimate of 30.00 and a low estimate of 14.00. The median estimate represents a +218.97% increase from the last price of 5.80.
The current consensus among 6 polled investment analysts is to Buy stock in Evoke Pharma Inc. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.